Hypoxia and vascular endothelial growth factor expression in human squamous cell carcinomas using pimonidazole as a hypoxia marker

Cancer Research

Volumn 58, Issue 17, 1998, Pages 3765-3768

  Raleigh, James A ^a   Calkins Adams, Dennise P ^a   Rinker, Lillian H ^a   Ballenger, Cynthia A ^a   Weissler, Mark C ^a   Fowler Jr , Wesley C ^a   Novotny, Debra B ^a   Varia, Mahesh A ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PIMONIDAZOLE; VASCULOTROPIN;

ARTICLE; CANCER STAGING; CLINICAL ARTICLE; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; HYPOXIA; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX CANCER;

BIOLOGICAL MARKERS; CARCINOMA, SQUAMOUS CELL; CELL HYPOXIA; ENDOTHELIAL GROWTH FACTORS; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; NITROIMIDAZOLES; UTERINE CERVICAL NEOPLASMS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0032170012     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Senger, D. R., Brown, L. F., Claffey, K. P., and Dvorak, H. F. Vascular permeability factor, tumor angiogenesis and stroma generation. Invasion Metastasis, 14: 385-394, 1994.
2. Forsythe, J. A., Jiang, B. H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., and Semenza, G. L. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol. Cell. Biol., 16: 4604-4613, 1996.
3. Damert, A., Ikeda, E., and Risau, W. Activator protein 1 binding potentiates the hypoxia-inducible factor 1-mediated, hypoxia-induced transcriptional activation of vascular endothelial growth factor expression in C6 glioma cells. Biochem. J., 327: 419-423, 1997.
4. Shweiki, D., Itin, A., Soffer, D., and Keshet, E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature (Lond.), 359: 843-845, 1992.
5. Leith, J. T., and Michelson, S. Secretion rates and levels of vascular endothelial growth factor in clone A or HCT-8 human colon tumour cells as a function of oxygen concentration. Cell Prolif., 28: 415-430, 1995.
6. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R., and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55: 3964-3968, 1995.
7. Obermair, A., Kohlberger, P., Bancher, T. D., Tempfer, C., Sliutz, G., Leodolter, S., Reinthaller, A., Kainz, C., Breitenecker, G., and Gitsch, G. Influence of microvessel density and vascular permeability factor/vascular endothelial growth factor expression on prognosis in vulvar cancer. Gynecol. Oncol., 63: 204-209, 1996.
8. Weidner, N. Intratumor microvessel density as a prognostic factor in cancer. Am. J. Pathol., 147: 9-19, 1995.
9. Hockel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U., and Vaupel, P. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res., 56: 4509-4515, 1996.
10. Raleigh, J. A., Miller, G. G., Franko, A. J., Koch, C. J., Fuciarelli, A. F., and Kelly, D. A. Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours. Br. J. Cancer, 56: 395-400, 1987.
11. Arteel, G. E., Thurman, R. G., Yates, J. M., and Raleigh, J. A. Evidence that hypoxia markers detect oxygen gradients in liver: pimonidazole and retrograde perfusion of rat liver. Br. J. Cancer, 72: 889-895, 1995.
12. Azuma, C., Raleigh, J. A., and Thrall, D. E. Lifetime of hypoxic cells in spontaneous canine tumors. Radiat. Res., 148: 35-42, 1996.
13. Kennedy, A. S., Raleigh, J. A., Perez, G. M., Calkins, D. P., Thrall, D. E., Novotny, D. B., and Varia, M. A. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int. J. Radiat. Oncol. Biol. Phys., 37: 897-905, 1996.
14. Chapman, J. D., Franko, A. J., and Sharplin, J. A marker for hypoxic cells in tumours with potential clinical applicability. Br. J. Cancer, 43: 546-550, 1981.
15. Gross, M. W., Karbach, U., Groebe, K., Franko, A. J., and Mueller-Klieser, W. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids. Int. J. Cancer, 61: 567-573, 1995.
16. Cline, J. M., Rosner, G. L., Raleigh, J. A., and Thrall, D. E. Quantification of CCI-103F labeling heterogeneity in canine solid tumors. Int. J. Radiat. Oncol. Biol. Phys., 37: 655-662, 1997.
17. Raleigh, J. A., and Koch, C. J. Importance of thiols in the reductive binding of 2-nitroimidazoles to macromolecules. Biochem. Pharmacol., 40: 2457-2464, 1990.
18. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med., 3: 177-182, 1997.
19. Thomlinson, R. H., and Gray, L. H. The histological structure of some human lung cancers and the possible implications for radiotherapy. Br. J. Cancer, 9: 539-549, 1955.
20. Claffey, K. P., and Robinson, G. S. Regulation of VEGF/VPF expression in tumor cells: consequences for tumor growth and metastasis. Cancer Metastasis Rev., 15: 165-176, 1996.